Crohn disease Trials in Cleveland, United States
Conditions / Crohn disease / Cleveland, United States
Clinical trials for Crohn disease investigate a range of treatment strategies and patient populations.
30 total trials for this combination
Showing top 10 of 30 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00265122 | A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease | COMPLETED | PHASE2 |
| NCT00261976 | A Long-term Safety Study of Infliximab (Remicade) | COMPLETED | — |
| NCT03467958 | An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT03455751 | Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery | TERMINATED | NA |
| NCT02877134 | Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease | COMPLETED | PHASE2 |
| NCT03464136 | Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year | COMPLETED | PHASE3 |
| NCT03464097 | A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT04835506 | Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial | ACTIVE_NOT_RECRUITING | PHASE4 |
| NCT03440372 | Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT02596893 | Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease | TERMINATED | PHASE3 |